TPEX:4192 Market Cap

TPEX:4192 has a market cap or net worth of 745.50 million as of March 9, 2026. Its market cap has decreased by -40.11% in one year.

Market Cap

745.50M

Enterprise Value

571.56M

Revenue

26.26M

Ranking

n/a

PE Ratio

n/a

Stock Price

20.90

Market Cap Chart

Since August 29, 2013, TPEX:4192's market cap has decreased from 3.70B to 745.50M, a decrease of -79.83%. That is a compound annual growth rate of -11.99%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	745.50M	-14.86%
Dec 31, 2025	875.61M	-28.55%
Dec 31, 2024	1.23B	-9.24%
Dec 29, 2023	1.35B	-53.80%
Dec 30, 2022	2.92B	-20.00%
Dec 30, 2021	3.65B	-26.59%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BioLASCO Taiwan	751.71M
TaiwanJ Pharmaceuticals	616.94M
Eusol Biotech	863.10M
Vectorite Biomedical	588.72M
Neith	899.73M
NatureWise Biotech & Medicals	940.05M
TCI GENE	949.86M
Taiwan Advance Bio-Pharmaceutical	958.50M

Market Cap Rankings